跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 106,017 条关于
“Shandong Cancer Hospital”
全部
106,017
临床试验
82,300
药物
2,869
机构
3,240
资讯
17,608
11个月前
Dual CD19/CD22 CAR-T Therapy Achieves Durable Remission in Refractory Plasmablastic Lymphoma Case
去年
Thoracic Radiotherapy Plus EGFR-TKI Improves Outcomes in EGFR-Mutated NSCLC
去年
Aumolertinib Shows Significant PFS Benefit in EGFR-Mutated Stage III NSCLC
去年
Aumolertinib Extends Progression-Free Survival in Stage III EGFR-Mutated NSCLC
去年
Aumolertinib Shows Promise in NSCLC, Ivonescimab Outperforms Pembrolizumab, and Novel Therapies Emerge in Breast Cancer and Multiple Myeloma
去年
Shandong Xinhua Pharmaceutical Receives Approval for Pentazocine
去年
Shandong Xinhua Pharma Gains Approval for Febuxostat Tablets in China
去年
Shandong Xinhua Pharmaceutical Receives Approval for Generic Cefuroxime Axetil Dispersible Tablets in China
3天前
Shandong Boan Biotechnology Receives CDE IND Clearance for BA1203
2年前
Myongji Hospital Develops AI-Powered Tool to Predict Ovarian Cancer Drug Resistance
第 1 页,共 1761 页
上一页
下一页